Almirall, a pharmaceutical company, is seeking participants for an upcoming meeting to better understand the experience of patients living with actinic keratosis.

If you reply Yes to all of the following questions, we would like the opportunity to speak with you about your interest in participating in this meeting.

Are you a resident of the United States?
Have you ever been diagnosed with actinic keratosis?
Were you first diagnosed at least 6 months ago?
Have you had 4 or more lesions in your lifetime?
Have you received 3 or more treatments for actinic keratosis, including cryotherapy (freezing) and/or topical therapies*? 

*Topical therapies include any of the following:
  • 5-Fluorouracil (Carac®, Efudex®, Fluoroplex®, Tolak®), Diclofenac (Solaraze®)
  • Imiquimod (Aldara™, Zyclara®)
  • Ingenol mebutate (Picato®)
  • Tirbanibulin (Klisyri®)
  • Topical 5-Fluorouracil 5%/Calcipotriene 0.005% cream (combination-based therapy)

Question Title

If you can respond Yes to all the questions above, please provide your email address and click the "submit" button below. Thank you for your consideration.